| Literature DB >> 31565193 |
Abstract
Aerobic capacity, which is expressed as peak oxygen consumption (VO2peak), is well-known to be an independent predictor of all-cause mortality and cardiovascular prognosis. This is true even for people with various coronary risk factors and cardiovascular diseases. Although exercise training is the best method to improve VO2peak, the guidelines of most academic societies recommend 150 or 75 min of moderate- or vigorous- intensity physical activities, respectively, every week to gain health benefits. For general health and primary and secondary cardiovascular prevention, high-intensity interval training (HIIT) has been recognized as an efficient exercise protocol with short exercise sessions. Given the availability of the numerous HIIT protocols, which can be classified into aerobic HIIT and anaerobic HIIT [usually called sprint interval training (SIT)], professionals in health-related fields, including primary physicians and cardiologists, may find it confusing when trying to select an appropriate protocol for their patients. This review describes the classifications of aerobic HIIT and SIT, and their differences in terms of effects, target subjects, adaptability, working mechanisms, and safety. Understanding the HIIT protocols and adopting the correct type for each subject would lead to better improvements in VO2peak with higher adherence and less risk. ©The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved.Entities:
Keywords: Aerobic capacity; Chronic heart failure; Coronary artery disease; Exercise; Health; High-intensity interval training; Lifestyle; Peak O2 consumption; Prevention; Training
Year: 2019 PMID: 31565193 PMCID: PMC6763680 DOI: 10.4330/wjc.v11.i7.171
Source DB: PubMed Journal: World J Cardiol
Variables improved by high-intensity interval training
| Skeletal muscle biopsy | |
| PGC-1α | |
| Mitochondrial function in lateral vastus | O2 consumption |
| Fatty acid transporter in the vastus lateralis and FAS (a key lipogenic enzyme) | |
| IR β subunit in skeletal muscle (peripheral insulin sensitivity) | Metabolic |
| Re-uptake of Ca2+ into the salcoplasmic reticulum | |
| Physiological test | |
| Exercise test | |
| Improvement of ventilatory efficiency (increased value of PETCO2) | Respiratory function |
| Oxygen consumption at the first ventilator threshold | Cardiac function |
| Oxygen pulse | Cardiac function |
| Parasympathetic activity (HR recovery) | Autonomic function |
| Duration of exercise time | Autonomic function |
| Distance walked during the 6-min walk | Work capacity |
| Ultrasonography | |
| Cardiac function | |
| Reversed LV re-modelling (LV end diastolic and systolic volumes) | Cardiac function |
| Ea | |
| Diastolic function (e′, E, E/ e′, E/A ratio, higher proportion of e′ > 8 cm/s, E improvement during exercise), | |
| Systolic function after 12 wk at rest and during exercise) | |
| E reduction | |
| Deceleration time increase | |
| Left atrial volume | |
| Reduced-plasma BNP | |
| Vascular | |
| Endothelial dysfunction (FMD) | Vascular function |
| Coronary plaque necrotic core reduction in defined coronary segments | Vascular function |
| Laboratory test | |
| Myeloperoxidase | Anti-oxidant |
| High sensitivity CRP | Inflammation |
| Interleukin-6 | |
| insulin sensitivity (HOMA index) | Metabolic |
| HbA1C | |
| Clinico-social data | |
| Increased Short Form-36 physical/mental component scores and decreased Minnesota Living with Heart Failure questionnaire score | Quality of life |
| Frequency of metabolic syndrome | Risk factor |
HOMA: Homoestasis model assessment; IR: Insulin receptor; PGC: Peroxisome-proliferator activated receptor γcoactivator; FMD: Flow mediated dilation; FAS: Fatty acid synthase; PETCO2: End-tidal carbon dioxide; HR: Heart rate; LV: Left ventricular; BNP: Brain natriuretic peptide.
Figure 1Schema of high-intensity interval training (HIIT) protocols. Adapted from Ito S. EC Cardiology 6.3 (2019): 196-200. HIIT is classified into two types: submaximal aerobic HIIT and all-out anaerobic HIIT [sprint interval training (SIT)]. Reduced-exertion HIIT (REHIT) is a low-dose and shorter SIT that is modified from SIT but is still an all-out anaerobic exercise. 4 × 4 min HIIT: four 4-min intervals at 90%-95% of maximal heart rate separated by 3-min active recovery periods of moderate intensity at 60%-70% of the maximal heart rate. Classic SIT: repeated (6-8) all-out bouts at vigorous intensity ~350% of VO2peak of short duration (30 s) followed by a long complete rest (2-5 min). REHIT: 10-min cycling session at 25 W interspersed with 1 (first session) or 2 (all remaining sessions) Wingate-type cycle-sprints against a constant torque of 0.65 Nm・kg lean mass−1. Sprints last 10 s in sessions 1-4, 15 s in sessions 5-12, and 20 s in the remaining 12 sessions.
Mode, intensity, and VO2peak increment in high-intensity interval training versus moderate-intensity continuous training in randomized controlled trials (coronary artery disease)
| 1 Rognmo et al[ | 2004 | CAD | 17 (HIIT = 8) | 3 d/wk 4 x 4 min@80%-90% VO2peak total 33min | 3 d/wk 41 min@50%-60% VO2peak isoload to HIIT | 10 wk | TM | 31.8 | 32.1 | 17.9 | 7.9 |
| 2 Warbur-ton et al[ | 2005 | CAD (previous CABG or AP) | 14 (HIIT = 7) | 2 d/wk, 2 min@90%VO2R, 2 min recovery, 30 min total | 2 d/wk 30 min @65%VO2R, average training volume similar to HIIT | 16 wk | TM | 22 | 21 | 31.8 | 9.5 |
| 3 Tjønna et al[ | 2008 | Metabolic syndrome | 28 (HIIT = 9) | 3 d/wk 4 × 4 min@90%HRmax, 3 min active recovery @70% HRmax 40 min total | 3 d/wk 47 min @70% HRmax, equalized training volume | 16 wk | TM | 33.6 | 36 | 35 | 16 |
| 4 Moholdt et al[ | 2009 | post CABG | 59 (HIIT = 28) | 5 d/wk 4 × 4 min@90%HRpeak, 3 min recovery | 5 d/wk 46 min + Aerobic group exercise, iso energic to HIIT | 4 wk | TM | 27.1 | 26.2 | 12.1 | 8.8 |
| 5 Moholdt et al[ | 2011 | post MI | 89 (HIIT = 30) | 2 d/wk 4 × 4 min@85%-95%HRpeak, 3 min recovery | 2 d/wk 60 min@58% PPO | 12 wk | TM1 | 31.6 | 32.2 | 14.6 | 7.8 |
| 6 Rocco et al[ | 2012 | CAD | 37 (HIIT = 17) | 3 d/wk 7 × 3 min@RCP, 7×3 min recovery@VAT total 42 min | 3 d/wk 50 min@VAT | 3 mo | TM | 18 | 17.9 | 23.3 | 24.6 |
| 7 Currie et al[ | 2013 | recent event CAD post PCI, CABG, | 22 (HIIT = 11) | 2 d/wk 10 × 1 min@89% (80%-104%) PPO, 1 min recovery@10%PPO, 1 d/wk home-based @similar intensity | 2 d/wk 30-50 min @58% PPO, 1d/wk home-based @similar intensity not isocaloric | 12 wk | bike | 19.8 | 18.7 | 24 | 19 |
| 8 Keteyian et al[ | 2014 | Stable CAD (post MI CABG and/or PCI) | 28 (HIIT = 15) | 3 d/wk 4 × 4 min@80%-90%HHR | 3 d/wk 30 min@60%-70%HRR | 10 wk | TM | 22.4 | 21.8 | 16 | 8 |
| 9 Madssen et al[ | 2014 | CAD with stents | 36 (HIIT = 16) | 3 d/wk 4 × 4 min@85%-95%HRpeak, 3 min active recovery@70%HRpeak | 3 d/wk 46 min@ 70%HRmax, isocaloric | 12 wk | TM | 31.2 | 29.8 | 10.6 | 6.7 |
| 10 Conraads et al[ | 2015 | CAD | 173 (HIIT = 85) | 3 d/wk 4 × 4 min@90%-95%HRpeak, 3 min active recovery | 3 d/wk 37 min@ 70%-75% %HRmax | 12 wk | bike | 23.5 | 22.2 | 22.7 | 20.3 |
Adapted from Ito S et al. Internal Medicine. 2016; 55: 2329-2336.
in VO2peak % increase raw: There is significant difference in % increase of VO2peak between HIIT and MCT. 4 × 4 min means 4 × 4 min intervals per one HIIT training session. Study 2: a data shown is VO2 at anaerobic threshold. Data is shown in figure without exact value at VO2peak (30+ in HIIT 30 in MCT)., and %increase at peak exercise is similar. TM etc1 means TM or stair climber,or, upper leg ergometer. Study 4: There was no difference at 4 wk: Increase of VO2peak between 4 wk and 6 mo was significant within HIIT and between HIIT and MCT. The participant attended additional sessions with various intensity at the center with their choice. Exercise was performed at center for 4 wk and at home for 6 mo. Study 5: TM1 means TM or aerobic exercise. AP: Angina pectoris; bike: Cycle ergometer; Cont: Continuous; CABG: Coronary artery bypass graft; CAD: Coronary artery disease; TM: Treadmill; HIIT: High-intensity interval training; HRpeak: Peak heart rate; HRR: Heart rate reserve; MCT: Moderate-intensity continuous training; PPO: Peak power output; RCP: Respiratory compensation point; VAT: Ventilator anaerobic threshold; VO2R: VO2 reserve; WRp: Peak work rate.
Mode, intensity, and VO2peak increment in high-intensity interval training versus moderate-intensity continuous training (congestive heart failure or diastolic dysfunction) in randomized
| 1 Dimo-poulos et al[ | 2006 | CHF | 24 (HIIT = 10) | 3 d/wk, 30 seconds@100% WRp, 30 s rest | 3 d/wk, 40 mins@50%WRp | 36 sessions | bike | 15.4 | 15.5 | 7.8 | 5.8 |
| 2 Wisloff et al[ | 2007 | CHF, Post MI | 27 (HIIT = 9) | 3 d (2 d supervised)/wk 4 × 4 min @90%-95%HRpeak, 3 min active recovery 50%-70% HRpeak, total 38 min | 3 d (2 d supervised)/wk, 47 min@70%-75% HRpeak, isoload to HIIT | 12 wk | TM | 13 | 13 | 46a | 14 |
| 3 Roditis et al[ | 2007 | CHF | 21 (HIIT = 11) | 3 d/wk 30 secc @WRpeak 30 s rest, total of 40 min | 3 d/wk 40 min@50%WRpeak, equal to total work of HIIT | 36 sessions | bike | 14.2 | 15.3 | 8.5 | 8.5 |
| 4 Smart et al[ | 2012 | CHF (LVEF< 35%) | 20 (HIIT = 10) | 3 d/wk 30 × 1 min @70% VO2peak, 1 min recovery | 3 d/wk 30 min@70%VO2peak, same absolute volume of work | 16 wk | bike | 12.2 | 12.4 | 21 | 13 |
| 5 Freyssin et al[ | 2012 | CHF (LVEF< 40%) | 26 (HIIT = 12) | 5 d/wk 12 × 30 sec@50% (4 wk) + 80% (4 wk) of maximum powerb 1 min @ complete rest | 5 d/wk 45 min@HRVT1c | 8 wk | Bike (HIIT), bike + TM (MCT) | 10.7 | 10.8 | 27.1a | 1.9 |
| 6 Fu et al[ | 2013 | CHF (LVEF≦40%) NYHA II, III | 45 (HIIT = 15) | 3 d/wk 5 × 3 min@80%VO2peak 3 min recovery@40% VO2peak | 3 d/wk 60 min @60% VO2peak, isoload to Int | 12 wk | bike | 16 | 15.9 | 22.5b | 0.6 |
| 7 Iellamo et al | 2013 | CHF with OMI (LVEF< 40%) | 20 (HIIT = 10) | 2-5 d/wk 2-4 × 4 min@75%-80%HRR, 3 min active pause walk@45%-50%HRR | 2-5 d/wk 30-45 min @45%-60%HRR, equated training load (TRIMPi) | 12 wk | TM | 18.7 | 18.4 | 8 22 | 4 22 |
| 8 Hollekim-Strand et al[ | 2014 | diastolic dysfunction with Diabetes mellitus | 37 (HIIT = 20) | 3 d/wk 4 × 4 min @90%-95%HRpeak, total 40 min | Current guideline 10 min/bout 210 min/wk) | 12 wk, Home-based thereafter | unknown | 31.5 | 33.2 | 13.0a | 3.6 |
| 9 Angadi et al[ | 2015 | CHF with preserved EF | 15 (HIIT = 9) | 3 d/wk 4 × 4 min @85%-90%HRpeak, 3 min active recovery | 3 d/wk 30 min@70%HRpeak | 4 wk | 19.2 | 16.9 | 9.4a | 0 | |
| 10 Ellingsen et al[ | SMARTex-HF, 2017 | Stable CHF (NYHA2-3) EF≦35% | 200 (3 arms) (HIIT=77) | 25 sessions 4 × 4 min@90%-95% HRpeak, 3 min active recovery 50%-70% HRpeak total 38 min | 25 sessions, 47 min@60-70%HRpeak | 12 wk | bike or TM | 0.9 | 1.1 | 5.4 | 6.8 |
| 11 Suchy C et al | OptimEX-CLIN, Ongoing | HFpEF | 180 (HIIT 60) | 3 d/wk 4 × 4 min@ 90%-95% HR peak, 3 min active recovery 50%-70% HRpeak, total 38 min | 5 d/wk 40 min@60%-70%HRpeak | 3, 12 mo, home-based after 3 mo | bike | ? | ? | ? | ? |
Controlled Trials Adapted from Ito S et al. Internal Medicine. 2016; 55: 2329-2336.
ain pre VO2peak % increase raw: There is significant difference in % increase of VO2peak between HIIT and MCT. Study 5: b each training session consisted of 3 series (12 repetitions of 30 s of exercises, separated by 5 minutes of rest); c half of the MCT was on a treadmill and half on a bike. Study 6: b pre versus post (not between groups). Study 7: Study hypothesis is similar adaptation in HIIT and MCT. Study 9: a evaluated by standardized effect size (d = 0.94) Bike: Cycle ergometer; CAD: Coronary artery disease; CHF: Congestive heart failure; EF: Ejection fraction; HRpeak: Peak heart rate; HIIT: High intensity interval training; HRVT1: Heart rate at the first ventilator threshold; HRR: Heart rate reserve; LVEF: Left ventricular ejection fraction; MCT: Moderate-intensity continuous training; MI: Myocardial infarction; min, minute; NYHA: New York Heart Association; RCP: Respiratory compensation point; VAT: Ventilator anaerobic threshold; PPO: Peak power output; TM: Treadmill; VO2peakR: VO2peak reserve; VT1: First ventilator threshold; WRp: Peak work rate.
High-intensity interval training (HIIT) protocol and superiority of HIIT to moderate-intensity continuous training in VO2peak improvement
| Coronary artery disease | 10 × 1 min | 1 | 0/1 |
| 8 × 2 min | 1 | 1/1 | |
| 7 × 3 min | 1 | 0/1 | |
| 4 × 4 min | 7 | 5/7 (70.2%) | |
| Chronic heart failure | 40 × 30 s | 3 | 1/3 |
| 30 × 1 min | 1 | 0/1 | |
| 5 × 3 min | 1 | 1/1 | |
| 4 × 4 min | 6 | 3/4 (75%) | |
| 56% (5/9) 2 studies ongoing |
Randomized controlled trials comparing improvement of VO2peak after exercise between HIIT and MCT in patients with CAD or CHF are shown. The protocols of HIIT and incidence of superiority of HIIT to MCT in each protocol are shown. In both groups 4×4 min was most frequently used showing positive rate 70.2% in the coronary artery disease group and 75% in the chronic heart failure group. The other protocols with 30 s, 2 min, and 3 min exercise duration are also effective in the limited number of studies. HIIT: High-intensity interval training; MCT: Moderate-intensity continuous training; CAD: Coronary artery disease; CHF: Chronic heart failure.
Figure 2Graphic representation of beneficial cardiovascular and metabolic effects and relevant mechanisms activated by high-intensity interval training. Glycolysis of glycogen granules in the skeletal muscle, catecholamine release, increased shear stress in the vessels, and increased autonomic nerve activity by HIIT are related to increased aerobic and metabolic capacities. Activity in skeletal muscle cells and arteries are increased during HIIT. The decrease in glycogen content by glycolysis results in the release of the AMP-activated protein kinase (AMPK) from the glycogen particle, resulting in greater activity and altered localization. In addition, exercise in a low-glycogen state after glycolysis leads to the phosphorylation and activation of peroxisome proliferator-activated receptor γ coactivator 1-α (PGC-1α). Finally, the osmotic stress associated with a rapid change in glycogen content and increased glucose concentration can activate mitogen-activated protein kinases (MAPKs) such as p38, which can phosphorylate and activate PGC-1. Another target of p38 is interleukin 6 (IL-6), which targets AMPK as one of the potential targets. These alterations in muscle signaling also result in improved circulating fatty acid (FA) utilization. The increased catecholamine level promotes an increase in fat metabolism by activating heat shock protein through protein kinase A. An additional cellular target of catecholamine is the cAMP response element-binding protein (CREB). HIIT can increase the phosphorylation and activation of CREB in both exercised muscle and muscles that were not recruited during the exercise due to the central effects of elevated central nervous system activity. One of the targets of CREB is PGC-1α. An increase in PGC-1α mRNA and protein with co-activation of the transcription factor results in the increase in the mRNA and protein of the mitochondrial oxygenation enzyme, and finally, improvements in physical fitness (aerobic capacity). HIIT increases cardiac output, leading to shear stress in arteries and resulting in improvements in endothelial function and pulse wave reflection potentially through endothelial microparticles.ACC: Acetyl CoA carboxylase; AMPK: AMP-activated protein kinase; CREB: cAMP response element-binding protein; HIIT: High-intensity interval training; IL-6: Interleukin 6; MAPK: Mitogen-activated protein kinases; PGC1α: Peroxisome proliferator-activated receptor γ coactivator 1-α; TF: Transcription factor.
Figure 3Personal proposal of high-intensity interval training (HIIT) protocols for target people stratified by age, exercise habits, and cardiovascular disease. 4 × 4 min HIIT: Can be adopted for all subjects, with the intensity maintained at 85%-95% of an individual ’s peak heart rate. Classic sprint interval training (SIT): The feasibility and safety of this protocol for patients complicated with cardiovascular disease have not been evaluated. Reduced-exertion HIIT (REHIT): Its feasibility and safety for patients complicated with cardiovascular disease have not been evaluated. Because REHIT is much less strenuous than classic SIT, future research on this protocol is expected for patients with stable cardiovascular diseases besides high-risk patients, such as those with refractory hypertension and coronary heart disease with atherosclerotic plaque. O: adaptable for all target subjects; Δ: potentially adaptable for target subjects without risk; ×: should be prohibited for all target subjects.